Effects of vanadium complexes on cell growth of human leukemia cells and protein-DNA interactions

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 9-15

  Lampronti, Ilaria ^a   Bianchi, Nicoletta ^a   Borgatti, Monica ^a   Fabbri, Enrica ^a   Vizziello, Leonardo ^a   Khan, Mahmud Tareq Hassan ^b,c   Ather, Arjumand ^c   Brezena, Dan ^d   Tahir, Mohammad Mahroof ^d   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY CHITTAGONG   (Bangladesh)

^c UNIVERSITY OF KARACHI   (Pakistan)

^d ST CLOUD STATE UNIVERSITY   (United States)

Author keywords

Anti tumor agents; Decavanadate; NF B; Transcription factor; Vanadium complexes

Indexed keywords

DNA BINDING PROTEIN; ERYTHROID SPECIFIC DNA BINDING FACTOR; GATA1 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGODEOXYRIBONUCLEOTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; VANADIUM DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN K 562; DOSE RESPONSE; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; HUMAN; LEUKEMIA; METABOLISM; PATHOLOGY; PROTEIN BINDING; SYNTHESIS;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GATA1 TRANSCRIPTION FACTOR; HUMANS; K562 CELLS; LEUKEMIA; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; TRANSCRIPTION FACTORS; VANADIUM COMPOUNDS;

EID: 24644437510     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Agarwal N and Gewirtz AM: Oligonucleotide therapeutics for hematologic disorders. Biochim Biophys Acta 1489: 85-96, 1999.
2. Praseuth D, Guieysse AL and Helene C: Triple helix formation and the antigene strategy for sequence-specific control of gene expression. Biochim Biophys Acta 1489: 181-206, 1999.
3. Gorman L and Glazer PM: Directed gene modification via triple helix formation. Curr Mol Med 1: 391-399, 2001.
4. Izumiya Y, Lin SF, Ellison T, Chen LY, Izumiya C, Luciw P and Kung HJ: Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J Virol 77: 1441-1451, 2003. (Pubitemid 36055565)
5. El-Tanani M, Femig DG, Barraclough R, Green C and Rudland P: Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors. J Biol Chem 276: 41675-41682, 2001.
6. Bianchi N, Chiarabelli C, Borgatti M, Mischiati C, Fibach E and Gambari R: Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine. Br J Haematol 113: 951-961, 2001. (Pubitemid 32634764)
7. Bianchi N, Osti F, Rutigliano C, Corradini FG, Borsetti E, Tomassetti M, Mischiati C, Feriotto G and Gambari R: The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells. Br J Haematol 104: 258-265, 1999. (Pubitemid 29083331)
8. Bianchi N, Ongaro F, Chiarabelli C, Gualandi L, Mischiati C, Bergamini P and Gambari R: Induction of erythroid differentiation of human K562 cells by cisplatin analogs. Biochem Pharmacol 60: 31-40, 2000. (Pubitemid 30243082)
9. Wozniak K, Czechowska A and Blasiak J: Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571. Chem Biol Interact 147: 309-318, 2004. (Pubitemid 38591500)
10. D'Cruz OJ and Uckun FM: Metvan: a novel oxovanadium (IV) complex with broad spectrum anticancer activity. Expert Opin Investig Drugs 11: 1829-1836, 2002.
11. Aubrecht J, Narla RK, Ghosh P, Stanek J and Uckun FM: Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes. Toxicol Appl Pharmacol 154: 228-235, 1999. (Pubitemid 29085234)
12. Messmore JM and Raines RT: Decavanadate inhibits catalysis by ribonuclease A. Arch Biochem Biophys 381: 25-30, 2000.
13. 2O: model studies for polyoxometalate-protein interactions. Comments Inorg Chem 16: 35-76, 1994.
14. Ohneda K and Yamamoto M: Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage. Acta Haematol 108: 237-245, 2002. (Pubitemid 35356700)
15. Cantor AB and Orkin SH: Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21: 3368-3376, 2002. (Pubitemid 34587709)
16. Chen F, Demers LM and Shi X: Upstream signal transduction of NF-kappaB activation. Curr Drug Targets Inflamm Allergy 1137-1149, 2002.
17. Hacker H and Karin M: Is NF-kappaB2/p100 a direct activator of programmed cell death? Cancer Cell 2: 431-433, 2002. (Pubitemid 41043946)
18. Bharti AC and Aggarwal BB: Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 64: 883-888, 2002. (Pubitemid 35238030)
19. Mahroof-Tahir M, Keramidas AD, Goldfarb RB, Anderson OP, Miller MM and Crans DC: Solution and solid state properties of [N-(2-Hydroxyethyl) iminodiacetato]-vanadium(IV), -(V), and - (IV/V) complexes. Inorg Chem 36: 1657-1668, 1997. (Pubitemid 127473262)
20. Crans DC, Khan AR, Mahroof-Tahir M, Mondal S, Miller SM, La Cour A, Anderson OP, Jakusch T and Kiss T: Bis (acetylamido)oxovanadium(IV) complexes: solid state and solution studies. J Chem Society, Dalton Transactions 379: 3337-3345, 2001.
21. Lozzio CB and Lozzio BB: Human chronic myelogenous leukemia cell-line with positive Philadelphia-chromosome. Blood 45: 321-334, 1975.
22. Feriotto G, Ciucci A, Mischiati C, Animati F, Lombardi P, Giacomini P, Arcamone F and Gambari R: Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues. Eur J Pharmacol 267-143-149, 1994.
23. Gambari R, Marks PA and Rifkind RA: Murine erythroleukemia cell differentiation: relationship of globin gene expression and of prolongation of G1 to inducer effects during G1/early S. Proc Natl Acad Sci USA 76: 4511-4515, 1979. (Pubitemid 9256511)
24. Gambari R, Terada M, Bank A, Rifkind RA and Marks PA: Synthesis of globin mRNA in relation to the cell cycle during induced murine erythroleukemia differentiation. Proc Natl Acad Sci USA 75: 3801-3804, 1978. (Pubitemid 8399288)
25. Penolazzi L, Lambertini E, Borgatti M, Piva R, Cozzani M, Giovannini I, Naccari R, Siciliani G and Gambari R: Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol 66: 1189-1198, 2003. (Pubitemid 37130294)
26. Crans DC: Aqueous chemistry of labile oxovanadates: of relevance to biological studies. Comments Inorg Chem 16: 1-33, 1994.
27. Baes CF and Mesmer RE (eds). Hydrolysis of Cations. John Wiley and Sons, Inc., New York, NY, pp193-210, 1976.
28. Boyd DB, Kustin K and Niwa M: Do vanadate polyanions inhibit phosphotransferase enzymes? Biochim Biophys Acta 827: 472-475, 1985.
29. Ashraf SM, Rajesh and Kaleem S: Interaction of decavanadate polyanions with proteins. Anal Biochem 230: 66-74, 1995.